The appropriate drug management of COPD is still based on the use of bronchodilators, possibly associated with an anti-inflammatory agent. However, there are still fundamental questions that require clarification to optimise their use and major unmet clinical needs that must be addressed.
Cazzola, M., Rogliani, P., Ora, J., Matera, M. (2016). Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. EXPERT OPINION ON PHARMACOTHERAPY, 17(7), 977-988 [10.1517/14656566.2016.1155555].
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease
CAZZOLA, MARIO;ROGLIANI, PAOLA;
2016-01-01
Abstract
The appropriate drug management of COPD is still based on the use of bronchodilators, possibly associated with an anti-inflammatory agent. However, there are still fundamental questions that require clarification to optimise their use and major unmet clinical needs that must be addressed.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
